Gilead Sciences News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

16.01.18	The Race To Find A Treatment For NASH (RTTNews)
12.12.17	Réouverture du service de radiologie à Plessisville (PR Newswire)
12.12.17	Living Drugs For Cancer - ASH Update (RTTNews)
11.12.17	Gilead: Kite Reveals Long-Term Data From Pivotal ZUMA-1 Study Of Yescarta (RTTNews)
08.12.17	Gilead Sciences To Buy Cell Design Labs In $567 Mln Deal (RTTNews)
28.11.17	Altiplano Increases Bulk Sample Stockpile to 600 tonnes, Delivers Initial 100 tonnes of Mineralized Material for Processing (PR Newswire)
28.11.17	China successfully completes the country's first human implantation of a retrievable transcatheter aortic valve (PR Newswire)
23.11.17	12e Concours Tournez-vous vers l'excellence! - Un lauréat dans la région de la Chaudière-Appalaches! (PR Newswire)
21.11.17	New Report Points to 'Honesty Divide' in Canadian Hiring Process (PR Newswire)
07.11.17	EllisDon Celebrated as Top Employer for 8th Consecutive Year (PR Newswire)
07.11.17	New Drugs Approved In October (RTTNews)
27.10.17	Biotech Stocks Facing FDA Decision In November (RTTNews)
26.10.17	Gilead Sciences Inc. Q3 Earnings Drop 19% (RTTNews)
25.10.17	CLSD Progressing With TYBEE, SNY In Legal Spat With MYL, TBPH On Watch (RTTNews)
24.10.17	Gilead: GS-0976 Leads To Reductions In Measures Of Liver Fat, Fibrosis (RTTNews)
24.10.17	In celebration of COSTI's 65th anniversary, COSTI announces recipients of the Excellence in Accelerating Engagement and Diversity Award, Entrepreneurship and Innovation Award and Lifetime... (PR Newswire)
22.10.17	Les résidents d'Edmonton profitent d'un espace culturel amélioré - Une aide financière de 72 000 dollars du gouvernement du Canada appuiera le Shumka Dance Centre (PR Newswire)
19.10.17	FDA Blesses 2nd CAR-T Cell Therapy, NVO One Step Away From Approval, AKTX Slumps (RTTNews)
18.10.17	Media iQ Brand Safety Measures Outperform Programmatic Industry Standard by 60%, Based on New Integral Ad Science (IAS) Study (PR Newswire)
16.10.17	Avesoro Resources Inc. - Acquisition of Heavy Mining Equipment and Disclosure of Smaller Related Party Transactions (PR Newswire)
14.10.17	Déclaration du ministre des Transports sur le déraillement d'un train de marchandises tout près du pont Sophie-Masson à Terrebonne, au Québec (PR Newswire)
13.10.17	Chemtrade Logistics Income Fund to Announce Third Quarter 2017 Results on November 14, 2017 (PR Newswire)
12.10.17	Governments of Canada and New Brunswick announce new housing options for victims of domestic violence (PR Newswire)
04.10.17	Gilead Presents Results From Study Of Patients Switched To Bictegravir-regimen (RTTNews)
04.10.17	Gilead To License Generic Production Of Bictegravir To MPP & Four Manufacturers (RTTNews)
03.10.17	/R E P R I S E -- Avis aux médias - Association canadienne de l'énergie éolienne (CanWEA) - 33e Congrès annuel et salon professionnel - Du 3 au 5 octobre 2017/ (PR Newswire)
29.09.17	Avis de ne pas consommer divers produits - Mise en garde à la population (PR Newswire)
29.09.17	Avis aux médias - Emploi et Développement social Canada (PR Newswire)
28.09.17	La raison avant les sentiments : Pourquoi les acheteurs doivent laisser leurs émotions à la porte (PR Newswire)
25.09.17	Gilead Sciences Announces Approval Of Sofosbuvir In China - Quick Facts (RTTNews)
21.09.17	Gilead: Canada OKs Updated Labeling Of EPCLUSA For HCV/HIV Co-infected Patients (RTTNews)
21.09.17	Gilead Receives Approval in Canada for Expanded Indication of EPCLUSA® (Sofosbuvir/Velpatasvir) for the Treatment of Chronic Hepatitis C in Patients Co-Infected with HIV (PR Newswire)
21.09.17	Gilead a obtenu l'approbation au Canada pour une indication étendue de EPCLUSA(MD) (sofosbuvir/velpatasvir) dans le traitement de l'hépatite C chronique chez les patients co-infectés par le VIH. (PR Newswire)
12.09.17	Companies to Watch as Biotech Makes a Comeback in 2017 (PR Newswire)
01.09.17	Stock Score Reports for Chesapeake Energy, Ford, General Electric, Gilead Sciences and Snap Inc. (PR Newswire)
01.09.17	SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Kite Pharma, Inc. - KITE (PR Newswire)
29.08.17	Biotechs Jump on Major Acquisitions, FDA Clearance and Clinical Trial Developments (PR Newswire)
29.08.17	Biotechs Jump on Major Acquisitions, FDA Clearance and Clinical Trial Developments (PR Newswire)
29.08.17	So Long To KITE; JUNO, CLLS, MBIO, BLCM Are Sympathy Plays; PGNX Catches Eye (RTTNews)
28.08.17	Gilead Sciences To Buy Kite Pharma For $180/shr - Quick Facts (RTTNews)
25.08.17	Technical Snapshots for these Biotech Stocks -- Gilead Sciences, Biogen, bluebird bio, and BioMarin Pharma (PR Newswire)
17.08.17	Gilead Sciences: VOSEVI Approved In Canada For Re-treatment Of HCV Infection (RTTNews)
16.08.17	Biotech Sector Rises on Accelerated Anti-cancer Drug Candidate Developments and Clinical Trial Progress (PR Newswire)
16.08.17	Biotech Sector Rises on Accelerated Anti-cancer Drug Candidate Developments and Clinical Trial Progress (PR Newswire)
02.08.17	FDA Nod For AGIO's IDHIFA, BMY Expands Opdivo Use, OCUL Reduces Headcount (RTTNews)
31.07.17	Biotech Stocks Facing FDA Decision In August (RTTNews)
31.07.17	DVAX Surges On FDA Panel Vote, CYTR On Watch, EU Approves New HCV Drugs (RTTNews)
28.07.17	Gilead Reports Authorization Of Vosevi, Extended Indication For Harvoni In EU (RTTNews)
26.07.17	Gilead Revises 2017 Guidance - Quick Facts (RTTNews)
26.07.17	Gilead Sciences Inc. Q2 Profit Falls 19% (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

17:58		Gute Stimmung in Europa: STOXX 50 klettert letztendlich
17:58		SPI aktuell: SPI verbucht letztendlich Abschläge
17:58		Schwacher Handel in Zürich: SMI zum Ende des Mittwochshandels im Minus
17:58		Handel in London: FTSE 100 fällt schlussendlich
17:58		Schwacher Handel in Zürich: SLI präsentiert sich schlussendlich schwächer

17:58

Gute Stimmung in Europa: STOXX 50 klettert letztendlich

17:58

SPI aktuell: SPI verbucht letztendlich Abschläge

17:58

Schwacher Handel in Zürich: SMI zum Ende des Mittwochshandels im Minus

17:58

Handel in London: FTSE 100 fällt schlussendlich

17:58

Schwacher Handel in Zürich: SLI präsentiert sich schlussendlich schwächer

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Logitech Intl	74.04	2.41 %	K V
ABB	52.12	1.68 %	K V
Geberit	552.80	1.32 %	K V
Alcon	78.04	1.19 %	K V
CieFinRichemont	129.05	1.10 %	K V
Swiss Life Hldg	686.00	-0.64 %	K V
Zurich Insur Gr	555.20	-1.00 %	K V
Holcim	90.66	-1.31 %	K V
Kuehne+Nagel Int	210.60	-1.31 %	K V
Novartis	90.10	-3.14 %	K V

Nachrichten zu Gilead Sciences Inc.

Aktien Top/Flop

Gilead Sciences Peer Group Nachrichten

Meistgelesene Nachrichten